CHAPTER 2: Key figures in 2024
Administrative aspects
Financial information
The Agency's total revenue in 2024 was EUR 502.59 million, a 9 % increase compared to EUR 461.54 million in 2023. In addition, the Agency operates with fund sources for assigned revenue, mainly CL for internal assigned revenue (rent and building charges received from the Agency's subtenant in London) and R0 for external assigned revenue. In 2024, assigned revenue (funding sources R0 and CL) amounted to EUR 10.46 million.
Preparing for the new fee regulation
Following the adoption of a revised regulation on fees and charges payable to EMA (Regulation (EU) 2024/568), the Agency focused on preparing for the implementation of the new regulation throughout 2024, to be ready for its implementation on 1 January 2025. The regulation aims to ensure the sustainability of the European medicines regulatory network, providing a sound financial basis to support its operations, as well as the objectives outlined in the European medicines agencies network strategy.
Preparations included the drafting and updating of all relevant regulatory and legal documentation, such as the cooperation agreement with NCAs, Working Arrangements and Management Board decisions that replaced the previous fee implementing rules. In parallel, the Agency was involved in several technical developments, adapting and improving existing systems and launching new ones. The implementation was further supported by communication measures, such as webinars and the publication of Q&A documents, to guide stakeholders through the new regulation.
Remuneration to national competent authorities
The NCAs in the EU Member States receive a share of EMA's revenue from fees for the assessments they carry out on behalf of the Agency. In 2024, EMA paid a total of EUR 177.10 million to the NCAs, a 15 % increase over 2023. This figure includes payments for pharmacovigilance procedures, including the assessment of PSURs, PASS protocols and study results, and of pharmacovigilance-related referrals.
Agency staff
As of December 2024, the Agency had 1,013 staff members: 667 women and 346 men.